Patient News
Treatment advances, expert insights, and charity activities
From Age 1 to 76, from CAR-T Bridging to Second Transplant: The Full-Course Transplant Care Behind Nearly 1,500 HSCTs at Beijing GoBroad Boren Hospital
Drawing on experience from nearly 1,500 transplants, Beijing GoBroad Boren Hospital has developed a full-course transplant management approach for complex settings such as CAR-T bridging, second transplantation, and transplantation in older adults.
Medical AdvancesExpert Guide: CAR-T, the “Special Forces” of Cancer Treatment — Who May Benefit, and Is It Worth Considering?
The opening article in Beijing GoBroad Boren Hospital’s CAR-T Q&A series answers four questions patients commonly ask: how CAR-T works, when it should be considered, what outcomes may be possible, and how treatment-related risks are managed.
Expert InsightsDr. Jiao ZONG × Dr. Yuehui LIN: A 5% Blast Count Does Not Automatically Mean Relapse — How to Read a Bone Marrow Report
Two specialists explain the key findings in a blood and bone marrow cell morphology report from both laboratory and clinical perspectives, reminding patients that an increased blast count does not necessarily mean relapse and must be interpreted in context.
Expert InsightsCancer Treatment Updates: CAR-T Moves Earlier in Relapsed Myeloma, a New Bispecific Antibody Enters Priority Review, and Innovative Drugs Join China's Essential Medicines List
Three recent cancer-care updates: a new myeloma guideline moves CAR-T earlier in the treatment pathway, the world's first PD-L1/4-1BB bispecific antibody to reach the marketing stage has entered China's priority-review pathway, and the updated National Essential Medicines List adds a number of innovative therapies.
Medical AdvancesProfessor Jun Zhou: Managing Side Effects of Chemotherapy, Targeted Therapy, and Immunotherapy for Gastric Cancer — What You Can Handle at Home and When to Seek Care
Professor Jun Zhou explains the common and less obvious side effects of chemotherapy, targeted therapy, and immunotherapy for gastric cancer, and highlights six situations that require prompt medical attention.
Expert InsightsInternational Journal Publication | Dr. Yajing Zhang & Prof. Minghui Duan: First Global Report of Durable Treatment-Free Remission in Castleman Disease After CD19 CAR-T Therapy
Dr. Yajing Zhang of Beijing GoBroad Boren Hospital and Prof. Minghui Duan of Peking Union Medical College Hospital co-authored the first reported case of refractory Castleman disease achieving durable complete remission after CD19 CAR-T cell therapy.
Medical AdvancesDo I Really Need a Stem Cell Transplant? A Guide to Transplant Decisions Across Different Blood Disorders
Understand the key differences between autologous and allogeneic stem cell transplantation, how transplant indications and donor selection vary by disease, and where transplantation fits in the CAR-T era.
Expert InsightsDon't Miss Hidden Spread in Lung Cancer: Recognizing Leptomeningeal Metastasis
Dr. Shuang LI uses a clinical case to explain the subtle symptoms of leptomeningeal metastasis from lung cancer, the diagnostic value of black-blood MRI sequences, and the role of multidisciplinary care.
Expert Insights